Parkside Financial Bank & Trust Ultragenyx Pharmaceutical Inc. Transaction History

Parkside Financial Bank & Trust

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$33.72 - $46.33 $2,697 - $3,706	80 New	80 $3,000
Q2 2022 Jul 13, 2022	BUY	$45.8 - $85.4 $503 - $939	11 New	11 $1,000
Q1 2022 May 13, 2022	SELL	$62.2 - $84.4 $124 - $168	-2 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$73.71 - $87.86 $221 - $263	-3 Reduced 60.0%	2 $0
Q3 2021 Oct 29, 2021	BUY	$77.92 - $102.4 $389 - $512	5 New	5 $0

325

85.5M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on Parkside Financial Bank & Trust with notifications on news.